study question: Is venous thrombosis risk increased in pregnancies after in vitro fertilization? summary answer: The venous thrombosis incidence was significantly increased in pregnancies after in vitro fertilization; especially in the first trimester and in the first 6 weeks post-partum.
Introduction
Worldwide, numerous women achieve pregnancy by the aid of in vitro fertilization (IVF). Until recently, IVF treatment was regarded a risk factor for thrombosis based on reviews of case reports only (Chan and Ginsberg, 2006; Girolami et al., 2007; Chan and Dixon, 2008; Chan, 2009) . During IVF, controlled ovarian stimulation leads to multiple oocytes and supra-physiological levels of estrogens. The consequence is a pro-coagulant like state during pregnancy (Bremme, 2003; Nelson and Greer, 2008; Szecsi et al., 2010) . Pregnancy per se increases the risk of venous thromboembolism (VTE), especially during the third trimester and the first 6 weeks after delivery (Andersen et al., 1998; Bremme, 2003; Virkus et al., 2011) . VTE, especially pulmonary embolism, remains a leading cause of maternal mortality (Cantwell et al., 2011) .
Four studies have provided important evidence on the issue of whether IVF is a risk factor for VTE. Jacobsen et al. found that the VTE risk during pregnancy and the post-partum period was significantly increased compared with other pregnancies, and Henriksson et al. and Rova et al. showed a significantly increased VTE risk among IVF-pregnancies during the first trimester (Jacobsen et al., 2008; Rova et al., 2012; Henriksson et al., 2013) . Our group recently reported no evidence of increased VTE risk after IVF treatment in unsuccessful cycles (Hansen et al., 2012) .
The aim of the present study was to investigate if the VTE risk is indeed increased during pregnancy and the post-partum period following IVF.
Methods

Population and registers
This was a national register-based cohort study. Since 1994, all IVF treatments in Denmark, including intracytoplasmic sperm injection, in both private and public clinics must be reported to the National In Vitro Fertilisation register (IVF register) (Andersen et al., 1999) . We identified and included all women with one or more IVF treatments at public or private fertility clinics in Denmark from 1995 to 2005 and who achieved pregnancy. Women fertilized by frozen embryo replacement were not included, because the procedure does not involve medical ovarian stimulation. We also excluded treatments involving oocyte donation, because the information in the IVF register did not distinguish unambiguously between women donating and women receiving oocytes. From the IVF register, we obtained cycle-specific information on the type and date of treatment, and the occurrence of pregnancy, abortions and deliveries. The IVF register also includes information from the National Patient Registry on pregnancy outcomes.
Using the personal Danish civil registration number, we linked data obtained from the IVF register to information on inpatient and outpatient contacts at all Danish hospitals from the National Patient Registry, a nationwide administrative database. Diagnosis codes for VTE and selected comorbidity diagnoses were obtained from the National Patient Registry from 1995 to 2005. We used the International Classification of Diseases, 10th revision (ICD-10) codes on VTE: I26, I80.1-I82.9, O08.2, O08.7, O22.3, O22.5, O87.1, O87.3 and O88.2. Women with a diagnosis of venous or arterial thrombosis or malignant disease prior to the current pregnancy were excluded. Medical records of all women with a VTE were examined to verify the absence of thrombosis prior to the study period. Information on maternal body mass index, maternal smoking and delivery mode was obtained from the Medical Birth Registry, which is a sub-register within the National Patient Registry (Knudsen and Olsen, 1998) .
Information on the iatrogenic complication, ovarian hyperstimulation syndrome (OHSS), was drawn both from the IVF register and the National Patient Registry.
Reference data
We used a recently published study by Virkus et al. on VTE in pregnant and puerperal women in Denmark as a reference (Virkus et al., 2011) . The study included 727 VTE events among the 805 464 pregnancies recorded in the Danish National Patient Registry from 1995 to 2005 (Virkus et al., 2011) . We found the study population to be an optimal reference group for our present study. In our present study, we used the same register, the same study period, the same ICD-10 codes on VTE events and the same inclusion and exclusion criteria as the paper by Virkus et al., Virkus et al. presented VTE events and time at risk in 10 gestational age strata during pregnancy and in seven intervals dividing the first 12 weeks after delivery or miscarriage. In pregnant women, the incidence of VTE was associated with gestational age but, in contrast with non-pregnant women, it was not associated with maternal age or education. The paper did not distinguish between pregnancies leading to birth or to miscarriage nor between singleton and multiple pregnancies. Also, the paper did not distinguish between pregnancies obtained with and without IVF treatment. In the main analyses, we used the reference data as published, but in a supplementary analysis, we constructed reference incidence rates corresponding to non-IVF pregnancies by subtracting the number of VTE events and the time at risk of the IVF pregnancies from the events and times at risk published in the reference paper.
Statistical analysis
In the IVF register, we identified all pregnancies established by IVF treatment, using the date of embryo transfer as the start of pregnancy. For comparison with reference data, which used a gestational age scale starting at the last menstrual period, we added 2 weeks to the gestational age of IVF pregnancies. A woman could be included with more than one pregnancy, but in case of a VTE event in one pregnancy, any following pregnancies were excluded. Post-partum VTE-incidence was analysed after exclusion of women with gestational VTE. For IVF pregnancies, we illustrated the cumulative incidence by Kaplan-Meier curves, and the cumulative incidence corresponding to the reference rates was displayed in the same graph. The same principle was used to illustrate the incidence during the post-partum period. We compared the incidence rates for IVF pregnancies with the reference rates using Poisson regression, stratified by the time intervals used in the reference data. Thus, the incidence rate ratio estimates correspond to a standardized incidence ratio obtained by indirect standardization.
We examined the contribution of maternal risk factors on VTE risk. Parity was dichotomized into primiparous and multiparous women. Information on body mass index was missing until 2004. Information on caesarean section was available from 1997 to 2005. Data on thrombophilia diagnoses was of poor quality and therefore omitted from our study. We did not attempt to replace missing values of risk factors by imputation. The effect of known risk factors was estimated by binomial regression and expressed as relative risks. P-values of ,0.05 were considered statistically significant, and we used 95% confidence intervals (CI). The statistical software Stata w (Stata Corp), version 12.1, was used for all statistical analyses.
Ethical approval
The study was approved by the Danish Data Protection Agency (Journal number: 2010-41-5050). The study did not have to be notified in the Ethics Committee according to Danish law, as it was an entirely registerbased study. Approval of the review of medical records was given by The Danish Health and Medicines Authority (Journal number: 3-3013-121/1).
Results
A flow chart of inclusions and exclusions of the study population is shown in Fig. 1 . Descriptive statistics on the study population and pregnancies are shown in Table I . The IVF study population was older than the reference population with 78% aged 30 or older, compared with 45% aged 30 or older in the reference population. Multiple pregnancies comprised 21% of the IVF pregnancies, compared with 2.3% of all pregnancies in Denmark in 2005 (Statistics Denmark, http://statistikbanken.dk/ FOD8). Polycystic ovarian syndrome and OHSS were recorded in 2.6 and 2.9% of the IVF pregnancies. The presence of either condition was recorded in 0.2% of reference pregnancies.
Significantly higher incidence rates of both antepartum and postpartum VTE were found in our IVF population compared with the reference population (Table II and Fig. 2 ).
VTE during pregnancy
During pregnancy, VTE was recorded in 36 women; 7 events of pulmonary embolism and 29 events of deep venous thrombosis without embolization. The overall incidence rate ratio of VTE during pregnancy was 3.0 (95% CI 2.1 -4.3) compared with reference pregnancies. In a supplementary statistical analysis, comparing IVF pregnancies to the estimated incidence among non-IVF reference pregnancies, the incidence rate ratio for VTE was 3.2 (95% CI 2.3-4.5).
Trimester-specific incidence rate ratios in comparison to reference pregnancies for singleton pregnancies and multiple pregnancies were as follows: first trimester 5.9 (95% CI 2.7-13.0) and 8.0 (95% CI 2.5-25.5), second trimester 2.4 (95% CI 0.9-6.6) and 5.7 (95% CI 1.8-18.1), and third trimester 2.3 (95% CI 1.4-3.8) and 2.9 (95% CI 1.1-7.9). No VTEs were recorded in pregnancies ending in miscarriage. 
VTE post-partum
During the first 12 weeks post-partum, 12 VTEs were recorded; 3 were pulmonary embolism, and 9 were deep venous thrombosis. The VTE incidence was especially high during the first 6 weeks post-partum (Fig. 3) . Compared with reference pregnancies, the incidence rate ratio was 3.9 for multiple IVF pregnancies, but only 1.2 for singleton IVF pregnancies.
VTE in singleton IVF pregnancies versus multiple IVF pregnancies
We compared VTE risk in singleton and multiple pregnancies within our IVF study population (Table III) . Multiple IVF pregnancies had a significantly higher incidence of VTE post-partum compared with singleton IVF pregnancies, but antepartum the difference was small. Adjusting for caesarean section did not reduce the relative risk estimate (3.2 without adjustment; 3.9 with adjustment). Table III demonstrates the effects of known risk factors on VTE risk in our IVF population, estimated by binomial regression. The contribution of each risk factor is presented as a relative risk for VTE during pregnancy and post-partum (Table III) . Maternal age did not affect the VTE risk during pregnancy (Table III) . The post-partum VTE risk was highest in women over 35 years, but was not significantly different from that of younger women. There were no VTE cases in women aged 40 years or more in our study. Polycystic ovarian syndrome and OHSS increased the ante partum VTE risk 5-fold, though these risk factors were present only in a minority of cases. Three of the 10 VTEs during the first trimester occurred in women given the OHSS diagnosis. We compared just the first trimester VTE-incidence rates in women with and without the OHSS diagnosis and found an incidence rate ratio of 14.2 (95% CI 2.4-62). Smoking and parity did not significantly affect the VTE risk (Table III) . Caesarean section increased the post-partum VTE risk, but the increase was not significant (Table III) . 
Maternal risk factors
Discussion
Main findings and comparison with other studies
The principal finding of our study was a significantly increased VTE risk throughout pregnancy and the post-partum period in IVF pregnancies.
The excess VTE risk was most pronounced during the first trimester and the first 6 weeks post-partum. This is in agreement with previous studies (Jacobsen et al., 2008; Rova et al., 2012) , though the most recent studies did not find an increased VTE risk after the first trimester in IVF pregnancies (Rova et al., 2012; Henriksson et al., 2013) . The high first trimester VTE incidence was surprising, because IVF treatment has not itself been found to increase the VTE risk in unsuccessful cycles (Hansen et al., 2012) . We demonstrated that OHSS was a risk factor for first trimester VTE. However, OHSS was present in only a few VTE cases, and OHSS did not explain the majority of the VTE events. OHSS ranges from discrete abdominal discomfort to severe cases complicated by thrombosis (Golan et al., 1989; Editorial, 1991; Vloeberghs et al., 2009) . Non-severe forms of OHSS might be underreported. Severe forms of OHSS prompt admission to hospital, and from our clinical experience, we find it unlikely that these severe cases were unreported in our registries.
Our study demonstrated an increased VTE incidence during the third trimester for both singleton and multiple IVF pregnancies compared with the reference pregnancies. For comparison, the VTE incidence in the reference pregnancies peaked at a lower level around delivery and the first week post-partum (Virkus et al., 2011) . The high post-partum VTE incidence in our study population of IVF pregnancies may be explained by a higher percentage of multiple pregnancies and more frequent delivery by caesarean section in IVF pregnancies (Romundstad et al., 2008; Rova et al., 2012) . Lindqvist et al. demonstrated that delivery by caesarean Thrombosis in pregnancies after IVF section is a risk factor for post-partum VTE (Lindqvist et al., 1999) ; this is in agreement with our finding. Previous studies have reported conflicting results on VTE risk in multiple IVF pregnancies compared with singleton IVF pregnancies (Jacobsen et al., 2008; Rova et al., 2012; Henriksson et al., 2013) . We found a higher post-partum VTE risk in multiple IVF pregnancies compared with singleton IVF pregnancies. However, the excess VTE risk was not attributable to a higher frequency of caesarean section in multiple pregnancies. The VTE risk during pregnancy was not significantly different in singleton IVF pregnancies versus multiple IVF pregnancies.
Our main statistical analyses used the reference data as published. However, the reference paper included both IVF pregnancies and non-IVF pregnancies without distinguishing between them, and the main analysis therefore underestimates the contrast between the two types. In a supplementary analysis, we illustrated the consequences: the incidence rate ratio between IVF pregnancies and non-IVF pregnancies was 3.2 rather than the 3.0 in the estimate from the main analysis when removing IVF pregnancies from the reference data.
In spontaneously conceived pregnancies, age over 35 years, obesity, smoking, thrombophilia, pre-eclampsia and multiple pregnancies are risk factors for antenatal VTE, while hypertension, increasing age and caesarean section are risk factors for post-natal VTE (Macklon and Greer, 1996; Lindqvist et al., 1999; Larsen et al., 2007; Lim et al., 2007; Jacobsen et al., 2008) .
The higher mean maternal age in our IVF population is in accordance with previous studies (Romundstad et al., 2008; Rova et al., 2012) . There was no association between maternal age and VTE incidence, neither in the reference data nor among IVF pregnancies. Henriksson et al. found an association between maternal age over 35 years and increased risk of VTE only in the overweight women (Henriksson et al., 2013) , while women aged .40 years had a doubled risk of VTE in the study by Rova et al. (2012) .
Conflicting results have been published on body mass index and VTE risk in IVF pregnancies (Rova et al., 2012; Henriksson et al., 2013) . We did not attempt to adjust for body mass index, because data were unavailable for most of the study period, as the Medical Birth Registry did not record body mass index before 2004. Two Swedish studies have demonstrated almost identical body mass index distribution in women receiving IVF compared with non-IVF women (Rova et al., 2012; Henriksson et al., 2013) . Assuming the same pattern in Denmark, adjustment for body mass index, if the data had been available, would hardly have affected the estimated associations between IVF treatment and VTE incidence.
In our study, smoking did not significantly affect VTE risk; other studies have reported conflicting results (Romundstad et al., 2008; Rova et al., 2012; Henriksson et al., 2013) .
In 2001, a Danish national guideline on thromboprophylaxis at caesarean section was developed in accordance with the British guideline from 1995, which recommended considering thromboprophylaxis in women with moderate or high risk of thrombosis (Royal College of Obstetricians and Gynaecologists, 1995) . During the study period, no Danish guideline existed for thromboprophylaxis in relation to IVF. A British guideline published in 2004 recommended thromboprophylaxis in women with severe OHSS and as optional in women with multiple risk factors for VTE and OHSS (Royal College of Obstetricians and Gynaecologists, 2004) . Women with previous thrombosis were excluded from both our study and the reference study. Hence, the VTE incidence was not influenced by anticoagulation therapy. If a few cases did receive thromboprophylaxis after IVF, this would only tend to underestimate the true risk of VTE in our study population.
Strengths and weaknesses
The large sample size and reference information originating from the same time period and using the same register and the same ICD-10 codes are major strengths of the present study. As our study is based on data from registers, it is not influenced by recall problems and nonresponses, and the authors have had no influence on the diagnostic process.
Access to data on known confounders in our reference population could have contributed to explain our results, but it could not have changed the conclusion that IVF pregnancies indeed have an increased risk of VTE compared with other pregnancies.
Misclassification of VTE diagnoses is possible (Severinsen et al., 2010) . However, Larsen et al. have reported moderate to high positive predictive values of ICD-10 VTE codes from the Danish National Patient Registry during pregnancy (Larsen et al., 2005) . Underreporting of VTE is possible, due to the fact that not all VTE patients are admitted to hospital. We approached this problem by inclusion of both inpatient and outpatient contacts. Any underreporting would affect IVF pregnancies and other pregnancies equally, thus not leading to bias in comparisons.
Conclusions and implications
Our study demonstrated that IVF is a risk factor for VTE throughout pregnancy and the post-partum period. IVF treatment should be included in the antenatal and post-natal risk assessment for VTE.
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